The reiteration of a Buy rating combined with an increased price target by a reputable analyst like Robyn Karnauskas signals a strong vote of confidence in Merck & Co's future performance. This is likely to be viewed positively by the market, potentially leading to a short-term increase in the stock price as investors react to the analyst's upgraded outlook.